#223: Challenges in Exceeding the Quality of Existing Endpoints and Approaches Using Digital Tools
Tuesday, June 18, 2024 10:00 AM to 11:00 AM · 1 hr. (US/Pacific)
Room 6B
03: Data-Tech
Information
This forum will discuss how novel technologies provide the means to measure new endpoints and can assess existing endpoints in new ways. Regulatory models are needed to encourage the acceptance of these novel approaches.
CE
ACPECMERN
Session Level
Intermediate
Featured Topics
Digital Technology
Speakers
JT
Julie Tai
Director, GRA, Precision Medicine and Digital HealthGlaxoSmithKlineJS
Jeffrey Siegel
Director, Office of Drug Evaluation Sciences, OND, CDERFDA
Lauren Oliva
US Regulatory Policy LeadBiogenRK
Rasika Kalamegham
Head, US Regulatory PolicyGenentech, A Member of the Roche GroupRB
Rob Berlin
Executive Director Regulatory PolicyVertex Pharmaceuticals